| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |